文献速递肾小球疾病

系统给予人Muse细胞对阿霉素肾病有益作用

Beneficial Effects of Systemically Administered Human Muse Cells in Adriamycin Nephropathy.
PubMed 文献 · J Am Soc Nephrol · 2017-07-03

该研究在阿霉素诱导的FSGS小鼠模型中系统给予人骨髓来源Muse细胞,不联用免疫抑制剂。Muse细胞优先归巢至受损肾小球并自发分化为足细胞、系膜细胞和内皮细胞,减轻肾小球硬化和间质纤维化,改善肾功能;但免疫排斥可削弱远期功能恢复。

要点

  • 人Muse细胞可归巢至FSGS受损肾小球并自发分化为足细胞、系膜细胞和内皮细胞。
  • 系统给予Muse细胞可减轻肾小球硬化与间质纤维化并改善肌酐清除率。
  • 免疫排斥影响Muse细胞存活,进而削弱远期功能恢复。

核心结论

  • Muse细胞是独特的修复性干细胞,系统给药后优先归巢至受损肾小球并自发分化为肾小球细胞,可能成为FSGS可行的治疗策略。

研究设计与样本

  • 在阿霉素诱导FSGS的SCID小鼠和BALB/c小鼠模型中,系统给予人骨髓来源Muse细胞,不联用免疫抑制剂。

主要发现

  • FSGS-SCID小鼠中,人Muse细胞优先整合入受损肾小球,自发分化为表达podocin的足细胞(31%)、表达megsin的系膜细胞(13%)和表达CD31的内皮细胞(41%),未与宿主细胞融合。
  • FSGS-SCID小鼠中,Muse细胞减轻肾小球硬化和间质纤维化,并在7周时诱导肌酐清除率恢复。
  • FSGS-BALB/c小鼠中,异种移植不联用免疫抑制剂在5周时产生类似效果,尿蛋白、肌酐清除率和血浆肌酐改善优于FSGS-SCID小鼠5周时。
  • FSGS-BALB/c小鼠7周时因免疫排斥导致功能恢复受损,提示Muse细胞作为肾小球细胞存活对组织修复和功能恢复重要。

临床怎么用

  • Muse细胞系统给药前无需引入分化诱导基因,可能简化FSGS细胞治疗流程。
  • 临床转化需考虑免疫排斥对Muse细胞存活和远期疗效的影响。

局限性

  • 研究为小鼠模型,样本量未报告。
  • FSGS-BALB/c小鼠7周时因免疫排斥功能恢复受损。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multilineage-differentiating stress-enduring (Muse) cells are nontumorigenic endogenous pluripotent-like stem cells that can be collected from various organs. Intravenously administered Muse cells have been shown to spontaneously migrate to damaged tissue and replenish lost cells, but the effect in FSGS is unknown. We systemically administered human bone marrow-derived Muse cells without concurrent administration of immunosuppressants to severe combined immune-deficient (SCID) and BALB/c mouse models with adriamycin-induced FSGS (FSGS-SCID and FSGS-BALB/c, respectively). In FSGS-SCID mice, human Muse cells preferentially integrated into the damaged glomeruli and spontaneously differentiated into cells expressing markers of podocytes (podocin; 31%), mesangial cells (megsin; 13%), and endothelial cells (CD31; 41%) without fusing to the host cells; attenuated glomerular sclerosis and interstitial fibrosis; and induced the recovery of creatinine clearance at 7 weeks. Human Muse cells induced similar effects in FSGS-BALB/c mice at 5 weeks, despite xenotransplant without concurrent immunosuppressant administration, and led to improvement in urine protein, creatinine clearance, and plasma creatinine levels more impressive than that in the FSGS-SCID mice at 5 weeks. However, functional recovery in FSGS-BALB/c mice was impaired at 7 weeks due to immunorejection, suggesting the importance of Muse cell survival as glomerular cells in the FSGS kidney for tissue repair and functional recovery. In conclusion, Muse cells are unique reparative stem cells that preferentially home to damaged glomeruli and spontaneously differentiate into glomerular cells after systemic administration. Introduction of genes to induce differentiation is not required before Muse cell administration; thus, Muse cells may be a feasible therapeutic strategy in FSGS.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Uchida N, Kushida Y, Kitada M, et al. Beneficial Effects of Systemically Administered Human Muse Cells in Adriamycin Nephropathy. J Am Soc Nephrol. 2017. PMID: 28674043. doi:10.1681/ASN.2016070775

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。